Piloting a neurogenetics service for drug resistant epilepsy patients

The goal is to demonstrate that this model of care in drug resistant epilepsy patients will significantly improve their healthcare and show that this can be delivered using available resources effectively and efficiently.

This project is being undertaken in the Vadlamudi Group.